N. Tsukada et al., CYTOTOXICITY OF T-CELLS FOR CEREBRAL ENDOTHELIUM IN MULTIPLE-SCLEROSIS, Journal of the neurological sciences, 117(1-2), 1993, pp. 140-147
We investigated the cytotoxic effect of peripheral blood T cells on ce
rebral endothelium in patients with MS. We examined in vitro the damag
e to Cr-51-labelled dissociated human brain endothelial cells produced
by mitogen-stimulated T cell lines from patients with MS and controls
. Endothelial targets were lysed by T-lymphocytes from patients with a
cute relapsing MS during an exacerbation at every target-effector cell
ratio tested compared with controls (P < 0.001). The percentage of en
dothelial targets lysed was not significantly increased by incubation
with T cells from patients with acute relapsing MS in remission and ch
ronic progressive MS, compared with that of normal subjects. Relapsing
MS patients during an exacerbation had significantly higher interleuk
in-1 (IL-1)-alpha concentrations in cultures of targets with effector
cells than normal subjects (P < 0.02). Experiments of major histocompa
tibility complex (MHC)-restricted cytotoxicity in MS demonstrated inco
mplete blocking of specific lysis by either anti-MHC class I or class
II monoclonal antibody (mAb). These results indicate that cytotoxicity
of T cells for cerebral endothelial cells may play a role in the init
iation of immune response in acute relapsing MS during an exacerbation
which appears to cause an increase in blood-brain barrier (BBB) perme
ability.